Abich Financial Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.81K Buy
87
+64
+278% +$5.88K 0.01% 245
2024
Q2
$2.73K Buy
23
+21
+1,050% +$2.66K ﹤0.01% 429
2024
Q1
$213 Buy
+2
New +$202 ﹤0.01% 478

Other funds holding MRNA

Abich Financial Wealth Management's MRNA Position: Q3 2024 in Review

Abich Financial Wealth Management increased its Moderna (MRNA) stake by 278% in Q3 2024, buying an estimated $5.88K and bringing the position to 87 shares worth $5.81K. The position accounts for 0.01% of the portfolio, ranked #245.

Abich Financial Wealth Management first reported a position in MRNA in Q1 2024 and has held it in 3 quarters since. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Abich Financial Wealth Management held 87 shares of Moderna worth $5.81K as of Q3 2024.
  • Abich Financial Wealth Management bought 64 Moderna shares in Q3 2024, an estimated $5.88K.
  • Moderna made up 0.01% of Abich Financial Wealth Management's portfolio in Q3 2024, its #245 holding.
  • Abich Financial Wealth Management first reported a position in Moderna in Q1 2024 and has held it in 3 quarters since.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.